HUI scientists have created a medication that protects human cells against damage and degeneration, allowing them to operate for long periods of time.
The breakthrough is related to its research, which is based on the discovery of a set of chemicals that allows for the repair of cells that deteriorate with time.
Professors Einav Gross and Shmuel Ben-Sasson of the HUJI’s college of medicine performed the research, which was published in the journal Autophagy.
The researchers studied the effects of numerous medicines on human longevity and quality of life, and they successfully demonstrated that the molecules can protect creatures and human cells from injury and prevent degeneration.
According to Prof. Gross,
Mitochondria, the cell’s power plants, are responsible for energy production. They can be compared to tiny electric batteries that help cells function properly. Although these ‘batteries’ wear out constantly, our cells have a sophisticated mechanism that removes defective mitochondria and replaces them with new ones.
This process is impeded by ageing, which causes cell dysfunction and tissue activity degeneration, resulting in an increasing number of age-related disorders such as Alzheimer’s, Parkinson’s, cardiac collapse, and Sarcopenia (loss of skeletal muscle mass and strength).
Read Also: The Safari Park Zoo in Lahore is auctioning off lions.
The research resulted in the creation of chemicals that have the ability to prevent and cure incurable illnesses. It also shown that the chemicals are safe for oral consumption.
Prof. Ben-Sasson continued,
In the future, we hope we will be able to significantly delay the development of many age-related diseases and improve people’s quality of life.
According to Itzik Goldwaser, CEO of Yissum, HUJI’s technology transfer company, “Ben-Sasson and Gross’ discoveries have significant value for the world ageing population.”
The research team launched Vitalunga, a business that is presently developing this drug in conjunction with Yissum, to continue the critical study and turn it into a medical therapy.
Goldwaser continued,
As Vitalunga advances towards pre-clinical studies, they’re closer than ever to minimizing the unbearable burden that aging-related diseases, such as Alzheimer’s and Parkinson’s, have on individuals, their families, and our health care systems.
